
Please try another search
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company’s flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysis of biological material of patients using swabs, urine, and saliva. It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas. Genomtec S.A. was incorporated in 2008 and is based in Wroclaw, Poland.
Name | Age | Since | Title |
---|---|---|---|
Gualtiero G. Garlasco | - | 2024 | Member of the Supervisory Board |
Pawel Duszek | - | 2023 | Independent Member of the Supervisory Board |
Andrzej Taudul | - | 2023 | Member of the Supervisory Board |
Beata Turlejska-Zdunczyk | 47 | 2024 | Independent Chairwoman of the Supervisory Board |
Trevor L. Hawkins | 56 | 2024 | Independent Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review